Pfizer oral antiviral safe and effective against SARS-CoV-2
Medical News Today - 08 Nov 2021Pfizer has recently published a paper demonstrating that its candidate antiviral drug is safe and has antiviral effects against SARS-CoV-2.
Pfizer
Pfizer has recently published a paper demonstrating that its candidate antiviral drug is safe and has antiviral effects against SARS-CoV-2.
Pfizer Loses Patent Over Compound To Treat Breast Cancer
Law360 - 02 Jul 2025Pfizer Loses Patent Over Compound To Treat Breast Cancer ...
Republicans subpoena former Pfizer exec over timing of COVID vaccine clinical tests
Fox Business - 02 Jul 2025Republicans subpoena former Pfizer exec over timing of COVID vaccine clinical tests ...
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
Business Wire - 26 Jun 2025Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors ...
FDA expands COVID vaccine warning about heart side effect risk for young males
CBS News - 21 May 2025FDA expands COVID vaccine warning about heart side effect risk for young males ...
Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland
CNBC - 12 Jun 2025Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland ...
FDA expands warnings of heart risks on COVID shots
Axios - 21 May 2025FDA expands warnings of heart risks on COVID shots ...
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
CNBC - 17 Jun 2025Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer ...
Pfizer Inc.
Britannica - 28 Jun 2025Pfizer Inc. ...
Pfizer: Competitive Advantages Still Exist, but Signs of Erosion Lead Us to Lower Our Valuation
Morningstar - 02 Jul 2025Pfizer: Competitive Advantages Still Exist, but Signs of Erosion Lead Us to Lower Our Valuation ...
Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer
Pfizer - 01 Jul 2025Pfizer Launches “Power of Knowing” Video Series with Chief Digital and Technology Officer ...
Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems
BioSpace - 01 Jul 2025Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems ...
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations
PR Newswire - 30 Jun 2025XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations ...
Pfizer terminates study of CD47 in blood cancer due to low recruitment
Yahoo Finance - 02 Jul 2025Pfizer terminates study of CD47 in blood cancer due to low recruitment ...
Pfizer reports positive results from Phase III BASIS trial for haemophilia
Clinical Trials Arena - 27 Jun 2025Pfizer reports positive results from Phase III BASIS trial for haemophilia ...
Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug
PharmiWeb.com - 02 Jul 2025Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug ...
Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook
MSN - 02 Jul 2025Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook ...
Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi
PMLiVE - 27 Jun 2025Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi ...
Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court
The Guardian - 14 May 2025Von der Leyen’s texts with Pfizer boss can be shared, says EU’s highest court ...
Pfizer ends Phase 2 trial for final Trillium CD47 drug
Endpoints News - 30 Jun 2025Pfizer ends Phase 2 trial for final Trillium CD47 drug ...